iVision Tech Inkomsten in het verleden
Verleden criteriumcontroles 2/6
iVision Tech has been growing earnings at an average annual rate of 230.3%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 50.9% per year. iVision Tech's return on equity is 12.8%, and it has net margins of 5.5%.
Belangrijke informatie
230.3%
Groei van de winst
n/a
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.3% |
| Inkomstengroei | 50.9% |
| Rendement op eigen vermogen | 12.8% |
| Nettomarge | 5.5% |
| Laatste winstupdate | 30 Jun 2023 |
Recente prestatie-updates uit het verleden
Geen updates
Opbrengsten en kosten
Hoe iVision Tech geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 23 | 10,724 | 590 | 4,353 | 0 |
| 31 Mar 23 | 10,111 | 436 | 4,185 | 0 |
| 31 Dec 22 | 9,497 | 282 | 4,018 | 0 |
| 31 Dec 21 | 4,751 | 77 | 3,344 | 0 |
Kwaliteitswinsten: IVN has a high level of non-cash earnings.
Groeiende winstmarge: IVN's current net profit margins (5.5%) are higher than last year (2.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Insufficient data to determine if IVN's year-on-year earnings growth rate was positive over the past 5 years.
Versnelling van de groei: Insufficient data to compare IVN's past year earnings growth to its 5-year average.
Winst versus industrie: IVN earnings growth over the past year (230.3%) exceeded the Medical Equipment industry 10.2%.
Rendement op eigen vermogen
Hoge ROE: IVN's Return on Equity (12.8%) is considered low.